Eribulin Impurities and its Related Products

Home > Impurities > Eribulin > Product Listing of Eribulin Impurities

Displaying 13 results of Eribulin Impurities

Eribulin is an anti-cancer drug used to treat breast cancer and liposarcoma. Eribulin Impurities are the unwanted substances that may be present in the drug during its manufacturing process. These impurities can affect the purity, quality and safety of the drug, and can also impact the effectiveness of the treatment. Therefore, it is important to identify and control these impurities to ensure that the drug is safe and effective for use in patients.

COMPOUND	CATEGORY	CAT. No.	CAS. No.	STOCK STATUS
ERIBULIN Dimer Impurity	Impurities	CS-O-33894	Not Available	Enquire
Eribulin Impurity 1	Impurities	CS-EO-03077	Not Available	Enquire
Eribulin Impurity 10	Impurities	CS-P-08800	Not Available	Enquire
Eribulin Impurity 12	Impurities	CS-P-08799	253128-15-3	Enquire
Eribulin Impurity 3	Impurities	CS-EO-03076	1534341-96-2	Enquire
Eribulin Impurity A	Impurities	CS-O-44904	Not Available	Enquire
Eribulin Impurity B	Impurities	CS-O-44913	Not Available	Enquire
Eribulin Impurity D	Impurities	CS-O-44914	Not Available	Enquire
Eribulin Mesylate Impurity C	Impurities	CS-O-36256	1534341-95-1	Enquire
Eribulin Mesylate Impurity E	Impurities	CS-O-36257	Not Available	Enquire
ERIBULIN N-Methyl Impurity	Impurities	CS-O-33893	253128-67-5	Enquire
ERIBULIN Propyl Impurity	Impurities	CS-O-33892	Not Available	Enquire
Methyl 3-(trimethylsilyl)-4-pentenoate	Impurities	CS-P-07820	185411-12-5	Enquire